Cargando…

Intranasal Administration of Agomir-let-7i Improves Cognitive Function in Mice with Traumatic Brain Injury

Overcoming the lack of drugs for the treatment of traumatic brain injury (TBI) has long been a major challenge for the pharmaceutical industry. MiRNAs have emerged as potential targets for progress assessment and intervention against TBI. The brain-enriched miRNA let-7i has been proposed as an ideal...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Xuan-Cheng, Wang, Jian, Du, Hong-Zhen, Liu, Chang-Mei, Teng, Zhao-Qian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027059/ https://www.ncbi.nlm.nih.gov/pubmed/35456028 http://dx.doi.org/10.3390/cells11081348

Ejemplares similares

Correction: He et al. Intranasal Administration of Agomir-let-7i Improves Cognitive Function in Mice with Traumatic Brain Injury. Cells 2022, 11, 1348
por: He, Xuan-Cheng, et al.
Publicado: (2022)

Agomir-331 Suppresses Reactive Gliosis and Neuroinflammation after Traumatic Brain Injury
por: Wang, Jin-Xing, et al.
Publicado: (2023)

Intranasal Administration of miR-146a Agomir Rescued the Pathological Process and Cognitive Impairment in an AD Mouse Model
por: Mai, Hui, et al.
Publicado: (2019)

Anxiolytic Action of Taurine via Intranasal Administration in Mice
por: Jung, Jung Hwa, et al.
Publicado: (2019)

Intranasal Administration of the Antisecretory Peptide AF-16 Reduces Edema and Improves Cognitive Function Following Diffuse Traumatic Brain Injury in the Rat
por: Clausen, Fredrik, et al.
Publicado: (2017)

A Combination of Let-7d, Let-7g and Let-7i Serves as a Stable Reference for Normalization of Serum microRNAs
por: Chen, Xi, et al.
Publicado: (2013)

Let-7i-5p represses brite adipocyte function in mice and humans
por: Giroud, Maude, et al.
Publicado: (2016)

An anti-let-7 sponge decoys and decays endogenous let-7 functions
por: Yang, Xiangling, et al.
Publicado: (2012)

An Agomir of miR-144-3p Accelerates Plaque Formation through Impairing Reverse Cholesterol Transport and Promoting Pro-Inflammatory Cytokine Production
por: Hu, Yan-Wei, et al.
Publicado: (2014)

Intranasal administration of acetylcholinesterase inhibitors
por: Costantino, Henry R, et al.
Publicado: (2008)

Dual mechanism of Let-7i in tumor progression
por: Zhou, Jiapei, et al.
Publicado: (2023)

Protective Effects of Let-7a and Let-7b on Oxidized Low-Density Lipoprotein Induced Endothelial Cell Injuries
por: Bao, Mei-hua, et al.
Publicado: (2014)

Promotion of allergic immune responses by intranasally-administrated nanosilica particles in mice
por: Yoshida, Tokuyuki, et al.
Publicado: (2011)

MiR-615 Agomir Encapsulated in Pluronic F-127 Alleviates Neuron Damage and Facilitates Function Recovery After Brachial Plexus Avulsion
por: Chen, Kangzhen, et al.
Publicado: (2021)

Intranasal ketamine versus intranasal fentanyl on pain management in isolated traumatic patients
por: Nasr Isfahani, Mehdi, et al.
Publicado: (2022)

In vivo pharmacological activity and biodistribution of S-nitrosophytochelatins after intravenous and intranasal administration in mice
por: Heikal, Lamia, et al.
Publicado: (2016)

Intranasal administration of resveratrol successfully prevents lung cancer in A/J mice
por: Monteillier, Aymeric, et al.
Publicado: (2018)

Intranasal human-recombinant NGF administration improves outcome in children with post-traumatic unresponsive wakefulness syndrome
por: Gatto, Antonio, et al.
Publicado: (2023)

Metabolic and Cognitive Outcomes of Subchronic Once-Daily Intranasal Insulin Administration in Healthy Men
por: Ritze, Yvonne, et al.
Publicado: (2018)

Effects of Intranasal Administration of Oxytocin and Vasopressin on Social Cognition and Potential Routes and Mechanisms of Action
por: Yao, Shuxia, et al.
Publicado: (2022)

Subacute Intranasal Administration of Tissue Plasminogen Activator Promotes Neuroplasticity and Improves Functional Recovery following Traumatic Brain Injury in Rats
por: Meng, Yuling, et al.
Publicado: (2014)

Intranasal and epicutaneous administration of Toll-like receptor 7 (TLR7) agonists provides protection against influenza A virus-induced morbidity in mice
por: To, Eunice E., et al.
Publicado: (2019)

Intranasal Administration of poly(I:C) and LPS in BALB/c Mice Induces Airway Hyperresponsiveness and Inflammation via Different Pathways
por: Starkhammar, Magnus, et al.
Publicado: (2012)

Oral Administration of Oxytocin, Like Intranasal Administration, Decreases Top-Down Social Attention
por: Zhuang, Qian, et al.
Publicado: (2022)

Role of let-7 family in the invasion and metastasis of osteosarcoma
por: Xiao, Tong, et al.
Publicado: (2023)

Intranasal GHK peptide enhances resilience to cognitive decline in aging mice
por: Tucker, Matthew, et al.
Publicado: (2023)

Prevention or Early Cure of Type 1 Diabetes by Intranasal Administration of Gliadin in NOD Mice
por: Funda, David P., et al.
Publicado: (2014)

Anti-obesity effect of intranasal administration of galanin-like peptide (GALP) in obese mice
por: Kageyama, Haruaki, et al.
Publicado: (2016)

Intranasal IL-4 Administration Alleviates Functional Deficits of Periventricular Leukomalacia in Neonatal Mice
por: Yu, Lin-chao, et al.
Publicado: (2020)

Intranasal administration of IL-35 inhibits allergic responses and symptoms in mice with allergic rhinitis
por: Suzuki, Motohiko, et al.
Publicado: (2017)

Taste Impairments in a Parkinson’s Disease Model Featuring Intranasal Rotenone Administration in Mice
por: Yin, Dong Xu, et al.
Publicado: (2022)

Clay Nanotubes Loaded with Diazepam or Xylazine Permeate the Brain through Intranasal Administration in Mice
por: Yanamadala, Yaswanthi, et al.
Publicado: (2023)

Utility of a Novel Micro-Spraying Device for Intranasal Administration of Drug Solutions to Mice
por: Suzuki, Naoto, et al.
Publicado: (2023)

Intranasal Administration of Mammary Tumour Milk Factor
por: Begg, A. M.
Publicado: (1949)

Design and Efficacy of Nanogels Formulations for Intranasal Administration
por: Aderibigbe, Blessing A., et al.
Publicado: (2018)

Inadequate quality of administration of intranasal corticosteroid sprays
por: Rollema, Corine, et al.
Publicado: (2019)

Pharmacokinetics of Nanosomal Form of Levodopa in Intranasal Administration
por: Nedorubov, Andrey Anatolievich, et al.
Publicado: (2019)

Intranasal Administration for Pain: Oxytocin and Other Polypeptides
por: Bharadwaj, Vimala N., et al.
Publicado: (2021)

Elevated Salivary Levels of Oxytocin Persist More than 7 h after Intranasal Administration
por: van IJzendoorn, Marinus H., et al.
Publicado: (2012)

Intranasal Administration of Oxytocin Attenuates Social Recognition Deficits and Increases Prefrontal Cortex Inhibitory Postsynaptic Currents following Traumatic Brain Injury
por: Runyan, Avery, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ge1a8534ctclgbf19dtqmumf9m